Doctors missing up to 64% sleep apnoea cases


Wednesday, 29 May, 2019


Doctors missing up to 64% sleep apnoea cases

The criteria doctors use to refer patients to a sleep study appear to be insufficient, missing over 60% of patients later found to have clinically relevant obstructive sleep apnoea, according to new research published in the Medical Journal of Australia.

Obstructive sleep apnoea (OSA) affects 9–38% of adults, is associated with high morbidity and mortality, and its health-related and other costs are high.

Until recently, OSA was predominantly managed by sleep specialists. Recent changes to the Medicare Benefits Schedule now allow primary care clinicians to directly refer patients for a sleep study if they have a positive result in at least two categories of the Berlin questionnaire (BQ), or an OSA-50 score of at least 5, or a score of at least 4 on the STOP-Bang questionnaire, if they also have an Epworth sleepiness score (ESS) of 8 or more.

However, according to research led by Professor Shyamali Dharmage, from the Allergy and Lung Health Unit at the University of Melbourne’s School of Population and Global Health, a significant number of OSA patients are being missed.

Dharmage and colleagues analysed data from 424 randomly selected participants in the Tasmanian Longitudinal Health Study with OSA symptoms, who completed OSA screening questionnaires and underwent type 4 sleep studies.

They found that STOP-Bang and OSA-50 correctly identified most participants with clinically relevant OSA, but with poor specificity; the specificity and sensitivity of the BQ were both low. When combined with the criterion ESS ≥8, the specificity of each questionnaire was high, but sensitivity was low. Sensitivity and specificity could be adjusted according to specific needs by varying the STOP-Bang cut-off score together with the ESS ≥8 criterion.

The researchers recommended that the “combined use of the STOP-Bang with different cut-off scores and the ESS facilitates a flexible balance between sensitivity and specificity”.

“Our STOP-Bang/ESS-based decision support tool may assist primary care physicians make objective and uniform decisions regarding OSA assessment and referral.”

Image credit: ©stock.adobe.com/au/Rafael Ben-Ari

Related Articles

GenesisCare expands with $35m Northern Beaches cancer centre

The relocated centre has expanded its services with a new radiation therapy offering and access...

In Conversation with Royal Women's Hospital CEO Sue Matthews

An hour after the final call for visitors to leave, Professor Sue Matthews — now CEO of...

Global prostate cancer rates predicted to double by 2040

The number of annual prostate cancer deaths worldwide is predicted to rise by 85% from 375,000 in...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd